ReShape receives Notice of Allowance for USPTO on Intragastric Device

ReShape Lifesciences (RSLS) announced that the company has received a Notice of Allowance from the U.S. Patent and Trademark Office, USPTO, for patent application 18/241,151, entitled, “Intragastric Device.” When issued, the patent will cover claims for an intragastric balloon system, comprising a swallowable capsule with a self-sealing fill valve and a degradable release valve designed to deflate and open the valve around three months after inflation with saline liquid, and configured for natural excretion after deflation, among other claim features. Once issued, the patent will provide protection into at least January 2031, without accounting for a potential Patent Term Extension, PTE.